INDO US BIOTECH
|
INDO US BIOTECH Last 5 Year Balance Sheet History
[Standalone]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
EQUITY AND LIABILITIES | |||||
Share Capital | ₹20 Cr | ₹10 Cr | ₹9.17 Cr | ₹6.07 Cr | ₹6.07 Cr |
Equity - Authorised | ₹21 Cr | ₹11 Cr | ₹10.00 Cr | ₹6.10 Cr | ₹6.10 Cr |
Equity - Issued | ₹20 Cr | ₹10 Cr | ₹9.17 Cr | ₹6.07 Cr | ₹6.07 Cr |
Equity Paid Up | ₹20 Cr | ₹10 Cr | ₹9.17 Cr | ₹6.07 Cr | ₹6.07 Cr |
Equity Shares Forfeited | - | - | - | - | - |
Adjustments to Equity | - | - | - | - | - |
Preference Capital Paid Up | - | - | - | - | - |
Face Value | ₹10.00 | ₹10.00 | ₹10.00 | ₹10.00 | ₹10.00 |
Share Warrants & Outstandings | - | - | - | - | - |
Total Reserves | ₹43 Cr | ₹44 Cr | ₹30 Cr | ₹15 Cr | ₹10 Cr |
Securities Premium | ₹22 Cr | ₹22 Cr | ₹15 Cr | ₹4.23 Cr | ₹4.23 Cr |
Capital Reserves | - | - | - | - | - |
Profit & Loss Account Balance | ₹21 Cr | ₹22 Cr | ₹15 Cr | ₹11 Cr | ₹6.14 Cr |
General Reserves | - | - | - | - | - |
Other Reserves | - | - | - | - | - |
Reserve excluding Revaluation Reserve | ₹43 Cr | ₹44 Cr | ₹30 Cr | ₹15 Cr | ₹10 Cr |
Revaluation reserve | - | - | - | - | - |
Shareholder's Funds | ₹63 Cr | ₹54 Cr | ₹39 Cr | ₹22 Cr | ₹16 Cr |
Minority Interest | - | - | - | - | - |
Long-Term Borrowings | - | - | - | - | - |
Secured Loans | ₹1.95 Cr | ₹1.41 Cr | ₹2.89 Cr | ₹2.08 Cr | ₹0.05 Cr |
Non Convertible Debentures | - | - | - | - | - |
Converible Debentures & Bonds | - | - | - | - | - |
Packing Credit - Bank | - | - | - | - | - |
Inter Corporate & Security Deposit | - | - | - | - | - |
Term Loans - Banks | ₹2.82 Cr | ₹2.46 Cr | ₹4.12 Cr | ₹2.51 Cr | ₹0.08 Cr |
Term Loans - Institutions | - | - | - | - | - |
Other Secured | ₹-0.87 Cr | ₹-1.05 Cr | ₹-1.23 Cr | ₹-0.42 Cr | ₹-0.03 Cr |
Unsecured Loans | ₹0.85 Cr | ₹0.29 Cr | ₹0.51 Cr | ₹1.28 Cr | ₹0.75 Cr |
Fixed Deposits - Public | - | - | - | - | - |
Loans and advances from subsidiaries | - | - | - | - | - |
Inter Corporate Deposits (Unsecured) | - | - | - | - | - |
Foreign Currency Convertible Notes | - | - | - | - | - |
Long Term Loan in Foreign Currency | - | - | - | - | - |
Loans - Banks | - | ₹0.20 Cr | ₹0.54 Cr | ₹0.96 Cr | ₹0.39 Cr |
Loans - Govt. | - | - | - | - | - |
Loans - Others | ₹0.03 Cr | ₹0.03 Cr | ₹0.03 Cr | ₹0.04 Cr | ₹0.04 Cr |
Other Unsecured Loan | ₹0.83 Cr | ₹0.06 Cr | ₹-0.06 Cr | ₹0.28 Cr | ₹0.32 Cr |
Deferred Tax Assets / Liabilities | ₹-0.66 Cr | ₹-0.59 Cr | ₹-0.42 Cr | ₹-0.26 Cr | ₹0.07 Cr |
Deferred Tax Assets | ₹0.66 Cr | ₹0.63 Cr | ₹0.52 Cr | ₹0.32 Cr | - |
Deferred Tax Liability | - | ₹0.05 Cr | ₹0.11 Cr | ₹0.06 Cr | ₹0.07 Cr |
Other Long Term Liabilities | ₹1.40 Cr | ₹0.93 Cr | ₹1.06 Cr | ₹0.79 Cr | ₹0.60 Cr |
Long Term Trade Payables | - | - | - | - | - |
Long Term Provisions | ₹0.04 Cr | ₹0.04 Cr | ₹0.04 Cr | ₹0.03 Cr | ₹0.05 Cr |
Total Non-Current Liabilities | ₹3.59 Cr | ₹2.09 Cr | ₹4.07 Cr | ₹3.92 Cr | ₹1.52 Cr |
Current Liabilities | - | - | - | - | - |
Trade Payables | ₹4.39 Cr | ₹1.40 Cr | ₹2.16 Cr | ₹8.86 Cr | ₹8.13 Cr |
Sundry Creditors | ₹4.39 Cr | ₹1.40 Cr | ₹2.16 Cr | ₹8.86 Cr | ₹8.13 Cr |
Acceptances | - | - | - | - | - |
Due to Subsidiaries- Trade Payables | - | - | - | - | - |
Other Current Liabilities | ₹2.34 Cr | ₹2.42 Cr | ₹3.13 Cr | ₹1.84 Cr | ₹1.14 Cr |
Bank Overdraft / Short term credit | - | - | - | - | - |
Advances received from customers | - | - | - | ₹0.15 Cr | ₹0.41 Cr |
Interest Accrued But Not Due | - | - | - | - | - |
Share Application Money | - | - | - | - | - |
Current maturity of Debentures & Bonds | - | - | - | - | - |
Current maturity - Others | - | - | - | - | - |
Other Liabilities | ₹2.34 Cr | ₹2.42 Cr | ₹3.13 Cr | ₹1.70 Cr | ₹0.73 Cr |
Short Term Borrowings | ₹10 Cr | ₹8.37 Cr | ₹6.82 Cr | ₹7.19 Cr | ₹7.07 Cr |
Secured ST Loans repayable on Demands | ₹10 Cr | ₹8.37 Cr | ₹6.82 Cr | ₹7.19 Cr | - |
Working Capital Loans- Sec | ₹10 Cr | ₹8.37 Cr | ₹6.82 Cr | ₹7.19 Cr | - |
Buyers Credits - Unsec | - | - | - | - | - |
Commercial Borrowings- Unsec | - | - | - | - | - |
Other Unsecured Loans | ₹-10 Cr | ₹-8.37 Cr | ₹-6.82 Cr | ₹-7.19 Cr | ₹7.07 Cr |
Short Term Provisions | ₹0.35 Cr | ₹0.10 Cr | ₹0.10 Cr | ₹0.08 Cr | ₹0.40 Cr |
Proposed Equity Dividend | - | - | - | - | - |
Provision for Corporate Dividend Tax | - | - | - | - | - |
Provision for Tax | ₹0.35 Cr | ₹0.10 Cr | ₹0.10 Cr | ₹0.08 Cr | - |
Provision for post retirement benefits | - | - | - | - | - |
Preference Dividend | - | - | - | - | - |
Other Provisions | ₹0.00 Cr | ₹0.00 Cr | ₹0.00 Cr | ₹0.00 Cr | ₹0.40 Cr |
Total Current Liabilities | ₹17 Cr | ₹12 Cr | ₹12 Cr | ₹18 Cr | ₹17 Cr |
Total Liabilities | ₹84 Cr | ₹69 Cr | ₹55 Cr | ₹43 Cr | ₹35 Cr |
ASSETS | |||||
Gross Block | ₹6.69 Cr | ₹7.37 Cr | ₹5.54 Cr | ₹2.33 Cr | ₹1.41 Cr |
Less: Accumulated Depreciation | - | - | - | - | - |
Less: Impairment of Assets | - | - | - | - | - |
Net Block | ₹6.69 Cr | ₹7.37 Cr | ₹5.54 Cr | ₹2.33 Cr | ₹1.41 Cr |
Lease Adjustment A/c | - | - | - | - | - |
Capital Work in Progress | ₹3.78 Cr | ₹1.37 Cr | ₹2.33 Cr | ₹1.99 Cr | ₹1.28 Cr |
Non Current Investments | - | - | ₹0.01 Cr | ₹0.01 Cr | - |
Long Term Investment | - | - | ₹0.01 Cr | ₹0.01 Cr | - |
Quoted | - | - | - | - | - |
Unquoted | - | - | ₹0.01 Cr | ₹0.01 Cr | - |
Long Term Loans & Advances | ₹0.24 Cr | ₹0.24 Cr | ₹0.23 Cr | ₹0.94 Cr | ₹0.08 Cr |
Other Non Current Assets | - | - | - | - | - |
Total Non-Current Assets | ₹11 Cr | ₹8.97 Cr | ₹8.10 Cr | ₹5.27 Cr | ₹2.77 Cr |
Current Assets Loans & Advances | - | - | - | - | - |
Currents Investments | - | - | - | - | - |
Quoted | - | - | - | - | - |
Unquoted | - | - | - | - | - |
Inventories | ₹52 Cr | ₹27 Cr | ₹23 Cr | ₹12 Cr | ₹9.15 Cr |
Raw Materials | - | - | - | - | - |
Work-in Progress | - | - | - | - | - |
Finished Goods | ₹47 Cr | ₹24 Cr | ₹19 Cr | ₹6.12 Cr | ₹3.22 Cr |
Packing Materials | ₹0.53 Cr | ₹1.18 Cr | ₹0.75 Cr | ₹0.48 Cr | ₹0.07 Cr |
Stores  and Spare | - | - | - | - | - |
Other Inventory | ₹4.30 Cr | ₹1.54 Cr | ₹3.22 Cr | ₹5.28 Cr | ₹5.85 Cr |
Sundry Debtors | ₹19 Cr | ₹25 Cr | ₹21 Cr | ₹25 Cr | ₹21 Cr |
Debtors more than Six months | ₹5.11 Cr | ₹7.50 Cr | ₹9.27 Cr | - | ₹7.81 Cr |
Debtors Others | ₹16 Cr | ₹20 Cr | ₹13 Cr | ₹26 Cr | ₹13 Cr |
Cash and Bank | ₹1.10 Cr | ₹0.19 Cr | ₹0.05 Cr | ₹0.13 Cr | ₹0.20 Cr |
Cash in hand | ₹0.00 Cr | ₹0.01 Cr | ₹0.05 Cr | ₹0.03 Cr | ₹0.19 Cr |
Balances at Bank | ₹1.10 Cr | ₹0.18 Cr | ₹0.00 Cr | ₹0.11 Cr | ₹0.01 Cr |
Other cash and bank balances | - | - | - | - | - |
Other Current Assets | ₹0.03 Cr | ₹0.02 Cr | ₹0.05 Cr | ₹0.06 Cr | ₹0.02 Cr |
Interest accrued on Investments | - | - | - | - | - |
Interest accrued on Debentures | - | - | - | - | - |
Deposits with Government | - | - | - | - | - |
Interest accrued and or due on loans | - | - | - | - | - |
Prepaid Expenses | ₹0.03 Cr | ₹0.02 Cr | ₹0.05 Cr | ₹0.06 Cr | ₹0.02 Cr |
Other current_assets | - | - | - | - | - |
Short Term Loans and Advances | ₹1.18 Cr | ₹8.05 Cr | ₹3.06 Cr | ₹1.37 Cr | ₹1.55 Cr |
Advances recoverable in cash or in kind | ₹1.09 Cr | ₹7.98 Cr | ₹2.93 Cr | ₹1.28 Cr | ₹0.03 Cr |
Advance income tax and TDS | - | - | - | - | - |
Amounts due from directors | - | - | - | - | - |
Due From Subsidiaries | - | - | - | - | - |
Inter corporate deposits | - | - | - | - | - |
Corporate Deposits | - | - | - | - | - |
Other Loans & Advances | ₹0.09 Cr | ₹0.07 Cr | ₹0.13 Cr | ₹0.10 Cr | ₹1.52 Cr |
Total Current Assets | ₹73 Cr | ₹60 Cr | ₹47 Cr | ₹38 Cr | ₹32 Cr |
Net Current Assets (Including Current Investments) | ₹56 Cr | ₹48 Cr | ₹35 Cr | ₹20 Cr | ₹15 Cr |
Miscellaneous Expenses not written off | - | - | - | ₹0.01 Cr | ₹0.03 Cr |
Total Assets | ₹84 Cr | ₹69 Cr | ₹55 Cr | ₹43 Cr | ₹35 Cr |
Contingent Liabilities | ₹0.98 Cr | ₹0.95 Cr | ₹0.67 Cr | ₹0.59 Cr | - |
Total Debt | ₹14 Cr | ₹12 Cr | ₹13 Cr | ₹11 Cr | ₹8.58 Cr |
Book Value | - | 54.35 | 42.41 | 35.47 | 27.05 |
Adjusted Book Value | 31.29 | 27.18 | 21.21 | 14.78 | 11.27 |
Compare Balance Sheet of peers of INDO US BIOTECH
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
INDO US BIOTECH | ₹501.1 Cr | -3.1% | -0.8% | 16.5% | Stock Analytics | |
BOMBAY BURMAH TRADING CORPORATION | ₹17,186.9 Cr | -3.9% | -6.7% | 67.7% | Stock Analytics | |
KAVERI SEED COMPANY | ₹4,228.8 Cr | -4% | -4.8% | 38.4% | Stock Analytics | |
VENKYS (INDIA) | ₹2,381.6 Cr | -1.3% | -1.2% | -15.9% | Stock Analytics | |
BOMBAY SUPER HYBRID SEEDS | ₹1,464.9 Cr | -7.3% | -13.4% | -38.7% | Stock Analytics | |
TIERRA AGROTECH | ₹397.4 Cr | 1.3% | -1.2% | -39.4% | Stock Analytics |
INDO US BIOTECH Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
INDO US BIOTECH | -3.1% |
-0.8% |
16.5% |
SENSEX | -1.9% |
-5% |
17.5% |
You may also like the below Video Courses